Integrated Wealth Concepts LLC cut its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 28.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,640 shares of the company's stock after selling 1,045 shares during the period. Integrated Wealth Concepts LLC's holdings in HCA Healthcare were worth $792,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Congress Wealth Management LLC DE lifted its stake in shares of HCA Healthcare by 3.4% in the 4th quarter. Congress Wealth Management LLC DE now owns 1,039 shares of the company's stock valued at $312,000 after purchasing an additional 34 shares during the period. Evergreen Private Wealth LLC lifted its stake in shares of HCA Healthcare by 0.3% in the fourth quarter. Evergreen Private Wealth LLC now owns 12,787 shares of the company's stock worth $3,838,000 after buying an additional 35 shares in the last quarter. Mediolanum International Funds Ltd increased its holdings in shares of HCA Healthcare by 0.3% in the 4th quarter. Mediolanum International Funds Ltd now owns 10,592 shares of the company's stock worth $3,153,000 after purchasing an additional 36 shares in the last quarter. Prairie Wealth Advisors Inc. raised its position in HCA Healthcare by 6.1% in the 4th quarter. Prairie Wealth Advisors Inc. now owns 700 shares of the company's stock worth $210,000 after buying an additional 40 shares during the last quarter. Finally, Whittier Trust Co. lifted its position in HCA Healthcare by 3.6% during the fourth quarter. Whittier Trust Co. now owns 1,195 shares of the company's stock valued at $359,000 after purchasing an additional 41 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the completion of the sale, the senior vice president now owns 15,412 shares of the company's stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.30% of the company's stock.
HCA Healthcare Price Performance
Shares of HCA stock traded up $5.07 during mid-day trading on Friday, hitting $348.11. 802,331 shares of the stock were exchanged, compared to its average volume of 1,400,124. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The firm has a fifty day moving average of $331.79 and a 200 day moving average of $330.21. The company has a market cap of $85.71 billion, a PE ratio of 15.84, a price-to-earnings-growth ratio of 1.10 and a beta of 1.48.
HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $5.75 by $0.70. The firm had revenue of $18.32 billion for the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The business's revenue was up 5.7% on a year-over-year basis. During the same quarter last year, the firm posted $5.36 EPS. Research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be paid a dividend of $0.72 per share. The ex-dividend date is Monday, June 16th. This represents a $2.88 annualized dividend and a yield of 0.83%. HCA Healthcare's dividend payout ratio (DPR) is currently 12.81%.
Analyst Upgrades and Downgrades
A number of brokerages have recently issued reports on HCA. Royal Bank of Canada cut their price objective on shares of HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Cantor Fitzgerald restated an "overweight" rating and set a $405.00 price target on shares of HCA Healthcare in a report on Monday, January 27th. Barclays lowered their price target on shares of HCA Healthcare from $392.00 to $366.00 and set an "overweight" rating for the company in a report on Monday, January 27th. Truist Financial dropped their price target on shares of HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Finally, Bank of America lowered their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, twelve have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $381.13.
View Our Latest Stock Analysis on HCA
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.